Benzinga | May 11, 2021 10:21AM EDT

Roth Capital Upgrades Kodiak Sciences to Buy, Lowers Price Target to $149

Roth Capital analyst Zegbeh Jallah upgrades Kodiak Sciences (NASDAQ:KOD) from Neutral to Buy and lowers the price target from $155 to $149.